Questions about treatment
How can I switch methylphenidate brands safely?
Do not assume that methylphenidate brands are a direct swap. Some are listed as equivalent; others release the medicine differently. Your prescriber and pharmacist should confirm the product, dose and instructions before you change.
Written and clinically reviewed by Adam OdusholaADHD Advanced Practitioner and Clinical Prescribing Pharmacist
Last updated: Last reviewed: Next review:Key points
- Do not assume that methylphenidate brands are a direct swap.
- Some are listed as equivalent; others release the medicine differently.
- Modified-release methylphenidate is prescribed and dispensed by brand name.
- Your prescriber and pharmacist should confirm the product, dose and instructions before you change.
Which brands are listed as equivalent?
Pick your brand to see which others are listed as a match for it, which can only be switched with particular care, and which only look similar.
Pick your brand to see which others can be switched with it, and which only look similar.
The full list, by group:
| Group | Brands or products | What this means |
|---|---|---|
| Listed prolonged-release tablets | Affenid XL, Atenza XL, Concerta XL, Delmosart, Matoride XL, Xaggitin XL and Xenidate XL | A clinician may arrange an equivalent-dose switch when appropriate |
| Listed 50:50 capsules | Focusim XL, Meflynate XL, Metyrol XL and Ritalin XL | A clinician may arrange a switch, while checking product-specific instructions |
| 50:50 capsule with a separate caution | Medikinet XL | Not completely equivalent to the other four capsules; food and interaction rules matter |
| No listed equivalent | Equasym XL | Requires specialist review rather than a direct brand swap |
| Not on the NHS list | Kixel XL and Tuzulby | Not included in the cited equivalent-brand groups: do not infer equivalence from tablet form, ingredient or release percentage |
Groups from the NHS list of equivalent brands. Matoride XL is licensed for children and young people only, so it is not a swap for adults. Equasym XL and Tuzulby are also licensed for ages 6 to 17.
Source: Prescribing and switching between modified-release methylphenidate.
What should I confirm before taking the new product?
- The full product name and strength.
- How many tablets or capsules to take, and when.
- Whether it is taken before, with or after food.
- Whether it must be swallowed whole or has specific opening or chewing instructions.
- Whether any of your other medicines affect it.
- When the change will be reviewed and who to contact if it does not suit you.
A matching milligram number is not enough when the release formulation differs.
Sources: Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations; Medikinet XL: Summary of Product Characteristics; Meflynate XL: Summary of Product Characteristics; Equasym XL: Summary of Product Characteristics; Tuzulby: Summary of Product Characteristics.
What dose would I take on a different product?
Each brand’s manufacturer publishes a table that lines its doses up with immediate-release methylphenidate, and the NHS list says which brands are switched at the same dose. The converter below puts those tables together. It is a guide for the conversation with your prescriber, not a prescription: your prescriber sets the dose, the start date and the review.
Choose what you take now and what you are changing to. The result shows how the published tables line up, and the day’s dose times before and after.
No listed match for 20 mg a day
Concerta XL’s conversion table lists immediate-release totals of 15, 30, 45, 60 mg a day. Your total is 20 mg a day, so your prescriber would choose between the nearest rows (15 mg and 30 mg a day) and review you.
- How to take it: swallow whole. Do not crush, cut or chew.
- This is a guide for the conversation with your prescriber, not a prescription. Your prescriber sets the dose, the start date and the review.
Doses from each product’s manufacturer conversion table and the NHS list of equivalent brands.
Where two brands have no published equivalence, the converter works through the immediate-release total that each brand’s own table gives and says so. Treat that as a starting point for your prescriber, not a swap.
Sources: Prescribing and switching between modified-release methylphenidate; Concerta XL: Summary of Product Characteristics; Ritalin XL: Summary of Product Characteristics; Medikinet XL: Summary of Product Characteristics; Equasym XL: Summary of Product Characteristics; Tuzulby: Summary of Product Characteristics.
What should I monitor after switching?
Record useful benefit across the day, appetite, sleep, mood and any physical symptoms. Follow the agreed pulse and blood-pressure monitoring plan.
Do not assume that a change in how you feel is imaginary. Equivalence supports prescribing decisions, but your experience still needs review.
Can I change to immediate-release methylphenidate instead?
Sometimes, but this changes the dosing schedule and may change coverage through the day. A prescriber needs to give you an individual plan. See the methylphenidate IR guide.
The dose converter above shows how your brand’s dose lines up with immediate-release methylphenidate and how the day’s doses would be spaced. Use it to prepare for the conversation, not to change your own doses.
Common questions
Can I swap Concerta XL and Xaggitin XL?
They are in the NHS equivalent-tablet group. Your prescriber or pharmacist should still confirm the prescribed strength, quantity and suitability for you.
My pharmacy gave me a different brand of methylphenidate. Is that allowed?
Modified-release methylphenidate should be prescribed and dispensed by brand name. If the pack is a different brand from your prescription, do not take it until the pharmacy has confirmed the change with your prescriber. If the prescription itself named the new brand, ask who agreed it and why, and check the food and swallowing instructions before your first dose.
Does 50:50 mean Medikinet XL is the same as Ritalin XL?
No. Sharing a release percentage does not remove the product differences. Medikinet XL needs particular care, including its food requirement.
Can Equasym XL be replaced directly by Tuzulby?
Do not make a direct swap. Their shared approximate release split does not establish equivalent dosing or identical effects.
Sources
- Prescribing and switching between modified-release methylphenidate. NHS Specialist Pharmacy Service
- Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations. MHRA Drug Safety Update
- Medikinet XL: Summary of Product Characteristics. eMC
- Meflynate XL: Summary of Product Characteristics. eMC
- Equasym XL: Summary of Product Characteristics. eMC
- Tuzulby: Summary of Product Characteristics. eMC
- Concerta XL: Summary of Product Characteristics. eMC
- Ritalin XL: Summary of Product Characteristics. eMC
This page is written for educational purposes and does not constitute medical advice. Always follow the guidance of your prescriber or pharmacist. If you have concerns about your medication, contact your clinical team.
About this page
- Written and clinically reviewed by
- Adam OdusholaADHD Advanced Practitioner and Clinical Prescribing Pharmacist
- First published
- Last updated
- Last reviewed
- Next review
“Last updated” is when the content last changed. “Last reviewed” is when it was last checked against current sources.
How this content is written, sourced and checked: editorial policy
Spotted an error? Report it by email. This is for website feedback only. It can’t give advice about your own treatment.